Showing results (271-280 of 426) with videos related to
Sort By:
Pageof 43
Cell|May 8, 2018
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary ElementSeung Woo Cho, Jin Xu, Ruping Sun, et al.Nature Cancer|February 5, 2022
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcomeGil Friedman, Oshrat Levi-Galibov, Eyal David, et al.Cell Reports|February 14, 2013
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factorHisham Mohammed, Clive D'Santos, Aurelien A Serandour, et al.Molecular Oncology|May 26, 2015
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potentialTesa M Severson, Justine Peeters, Ian Majewski, et al.Cell Reports|September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast CancerManikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.Cancer Research|June 27, 2019
EN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain MetastasisGuillermo Peluffo, Ashim Subedee, Nicholas W Harper, et al.Cell Reports|February 23, 2022
Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factorsNishanth Belugali Nataraj, Ashish Noronha, Joo Sang Lee, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis TrialJeremy St John Thomas, Elena Provenzano, Louise Hiller, et al.Nature Medicine|June 5, 2020
Author Correction: Caring for patients with cancer in the COVID-19 eraJoris van de Haar, Louisa R Hoes, Charlotte E Coles, et al.Nature Medicine|May 15, 2020
Caring for patients with cancer in the COVID-19 eraJoris van de Haar, Louisa R Hoes, Charlotte E Coles, et al.Pageof 43